Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

The first Korean case of 2p15p16.1 microdeletion syndrome, characterized by facial dysmorphism, developmental delay, and congenital hypothyroidism

  • Jin Young Cho (Department of Pediatrics, Chungnam National University College of Medicine) ;
  • Tae Kwan Lee (Department of Pediatrics, Chungnam National University Hospital) ;
  • Yoo Mi Kim (Department of Pediatrics, Chungnam National University College of Medicine) ;
  • Han Hyuk Lim (Department of Pediatrics, Chungnam National University College of Medicine)
  • Received : 2022.09.17
  • Accepted : 2022.10.31
  • Published : 2022.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The microdeletion syndrome of chromosome 2p15p16.1 (MIM: 612513) is an extremely rare contiguous gene deletion syndrome. Microdeletions of varying sizes in the 2p15-16.1 region are associated with developmental delay, intellectual disability, autism spectrum disorder, hypotonia, and craniofacial dysmorphism. Previous studies have identified two critical regions: the proximal 2p15 and distal 2p16.1 regions. BCL11A, PAPOLG, and REL genes play crucial roles in patients with 2p16.1 microdeletion. To our knowledge, only 39 patients have been reported as having 2p15p16.1 microdeletion syndrome. Here, we present another patient with 2p15p16.1 microdeletion syndrome. A nine-month-old boy was referred to our clinic for the psychomotor delay, facial dysmorphism, and congenital hypothyroidism. During his follow-up visits, he was diagnosed with global developmental delay, intellectual disability, abnormal behavior, hypotonia, microcephaly, and abnormal electroencephalography. Using a chromosomal microarray for genetic analysis, a novel, de novo, 622 kb microdeletion of 2p16.1 was identified as one of the critical regions of the 2p15p16.1 microdeletion syndrome. This is the first case of its kind in Korea. We have discussed our case and literature reviews to clarify the relationship between the genes involved and clinical phenotypes in 2p15p16.1 microdeletion syndrome.

Keywords

Acknowledgement

We thank the patient and his parents for their cooperation. This work was not supported by any funds.

References

  1. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a firsttier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64.  https://doi.org/10.1016/j.ajhg.2010.04.006
  2. Arican P, Olgac Dundar N, Ozyilmaz B, Cavusoglu D, Gencpinar P, Erdogan KM, et al. Chromosomal microarray analysis in children with unexplained developmental delay/intellectual disability. J Pediatr Genet 2019;8:1-9.  https://doi.org/10.1055/s-0038-1676583
  3. Rajcan-Separovic E, Harvard C, Liu X, McGillivray B, Hall JG, Qiao Y, et al. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1. J Med Genet 2007;44:269-76.  https://doi.org/10.1136/jmg.2006.045013
  4. Shimojima K, Okamoto N, Yamamoto T. Characteristics of 2p15-p16.1 microdeletion syndrome: review and description of two additional patients. Congenit Anom (Kyoto) 2015;55:125-32.  https://doi.org/10.1111/cga.12112
  5. Levy J, Coussement A, Dupont C, Guimiot F, Baumann C, Viot G, et al. Molecular and clinical delineation of 2p15p16.1 microdeletion syndrome. Am J Med Genet A 2017;173:2081-7.  https://doi.org/10.1002/ajmg.a.38302
  6. Hancarova M, Simandlova M, Drabova J, Mannik K, Kurg A, Sedlacek Z. A patient with de novo 0.45 Mb deletion of 2p16.1: the role of BCL11A, PAPOLG, REL, and FLJ16341 in the 2p15-p16.1 microdeletion syndrome. Am J Med Genet A 2013;161A:865-70. 
  7. Shimbo H, Yokoi T, Aida N, Mizuno S, Suzumura H, Nagai J, et al. Haploinsufficiency of BCL11A associated with cerebellar abnormalities in 2p15p16.1 deletion syndrome. Mol Genet Genomic Med 2017;5:429-37.  https://doi.org/10.1002/mgg3.289
  8. Bagheri H, Badduke C, Qiao Y, Colnaghi R, Abramowicz I, Alcantara D, et al. Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis. JCI Insight 2016;1:e85461. 
  9. Balci TB, Sawyer SL, Davila J, Humphreys P, Dyment DA. Brain malformations in a patient with deletion 2p16.1: a refinement of the phenotype to BCL11A. Eur J Med Genet 2015;58:351-4.  https://doi.org/10.1016/j.ejmg.2015.04.006
  10. Basak A, Hancarova M, Ulirsch JC, Balci TB, Trkova M, Pelisek M, et al. BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations. J Clin Invest 2015;125:2363-8.  https://doi.org/10.1172/JCI81163
  11. Chabchoub E, Vermeesch JR, de Ravel T, de Cock P, Fryns JP. The facial dysmorphy in the newly recognised microdeletion 2p15-p16.1 refined to a 570 kb region in 2p15. J Med Genet 2008;45:189-92. 
  12. Fannemel M, Baroy T, Holmgren A, Rodningen OK, Haugsand TM, Hansen B, et al. Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a patient with mild intellectual disability and cranio-facial dysmorphisms. Eur J Med Genet 2014;57:513-9.  https://doi.org/10.1016/j.ejmg.2014.05.008
  13. Mimouni-Bloch A, Yeshaya J, Kahana S, Maya I, Basel-Vanagaite L. A de-novo interstitial microduplication involving 2p16.1-p15 and mirroring 2p16.1-p15 microdeletion syndrome: Clinical and molecular analysis. Eur J Paediatr Neurol 2015;19:711-5.  https://doi.org/10.1016/j.ejpn.2015.07.013
  14. Amendola E, Sanges R, Galvan A, Dathan N, Manenti G, Ferrandino G, et al. A locus on mouse chromosome 2 is involved in susceptibility to congenital hypothyroidism and contains an essential gene expressed in thyroid. Endocrinology 2010;151:1948-58.  https://doi.org/10.1210/en.2009-1240
  15. Bakker B, Bikker H, Hennekam RC, Lommen EJ, Schipper MG, Vulsma T, et al. Maternal isodisomy for chromosome 2p causing severe congenital hypothyroidism. J Clin Endocrinol Metab 2001;86:1164-8.  https://doi.org/10.1210/jcem.86.3.7313
  16. Fu C, Xie B, Zhang S, Wang J, Luo S, Zheng H, et al. Mutation screening of the TPO gene in a cohort of 192 Chinese patients with congenital hypothyroidism. BMJ Open 2016;6:e010719. 
  17. Peter B, Matsushita M, Oda K, Raskind W. De novo microdeletion of BCL11A is associated with severe speech sound disorder. Am J Med Genet A 2014;164A:2091-6. 
  18. Maia N, Nabais Sa MJ, Melo-Pires M, de Brouwer APM, Jorge P. Intellectual disability genomics: current state, pitfalls and future challenges. BMC Genomics 2021;22:909. 
  19. Dias C, Estruch SB, Graham SA, McRae J, Sawiak SJ, Hurst JA, et al. BCL11A Haploinsufficiency causes an intellectual disability syndrome and dysregulates transcription. Am J Hum Genet 2016;99:253-74.  https://doi.org/10.1016/j.ajhg.2016.05.030
  20. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001;98:3413-20.  https://doi.org/10.1182/blood.V98.12.3413
  21. Funnell AP, Prontera P, Ottaviani V, Piccione M, Giambona A, Maggio A, et al. 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment. Blood 2015;126:89-93. 
  22. Korenke GC, Schulte B, Biskup S, Neidhardt J, Owczarek-Lipska M. A novel de novo frameshift mutation in the BCL11A gene in a patient with intellectual disability syndrome and epilepsy. Mol Syndromol 2020;11:135-40.  https://doi.org/10.1159/000508566
  23. Yoshida M, Nakashima M, Okanishi T, Kanai S, Fujimoto A, Itomi K, et al. Identification of novel BCL11A variants in patients with epileptic encephalopathy: expanding the phenotypic spectrum. Clin Genet 2018;93:368-73.  https://doi.org/10.1111/cge.13067
  24. Perumal K, Sinha K, Henning D, Reddy R. Purification, characterization, and cloning of the cDNA of human signal recognition particle RNA 3'-adenylating enzyme. J Biol Chem 2001;276:21791-6.  https://doi.org/10.1074/jbc.M101905200
  25. Beaussant-Cohen S, Jaber F, Massaad MJ, Weeks S, Jones J, Alosaimi MF, et al. Combined immunodeficiency in a patient with c-Rel deficiency. J Allergy Clin Immunol 2019;144:606-8.e4. https://doi.org/10.1016/j.jaci.2019.05.003